MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC) Meeting Abstract
| Authors: | Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; Gaillard, S.; Adams, S. F.; Duska, L. R.; Cappuccini, F.; Dalton, H.; Holloway, R. W.; Huang, M.; Chon, H. S.; Cloven, N. G.; ElNaggar, A.; O'Cearbhaill, R. E.; Waggoner, S. E.; Wang, Z.; Zhi, E.; Samnotra, V.; Konstantinopoulos, P. A. |
| Abstract Title: | MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301629 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.5573 |
| Notes: | Meeting Abstract: 5573 -- Source: Wos |
